Corporate results
- EasyJet: expects full-year profit to beat market expectations thanks to strong demand.
- Ericsson: Q1 EBIT exceeds expectations at SEK 4 bn.
- J.B. Hunt: stock fell after disappointing results.
- Sika: business contracted in Q1. 2023 targets confirmed.
- Johnson & Johnson advanced 2% in premarket trading after raising its annual profit forecast
- Bank of America saw its profit grow in the first quarter, benefiting from the Federal Reserve's rate hikes
- Goldman Sachs saw first-quarter profit fell to $3.09 billion from $3.83 billion a year earlier, due to a drop in global M&A activity.
- Lockheed Martin reported better-than-expected results as geopolitical tensions fueled demand from U.S. and international customers.
In other news
- Alphabet - Nine U.S. states, including Michigan and Nebraska, have joined a Justice Department lawsuit against Alphabet subsidiary Google, accused of violating antitrust law in the management of its digital advertising business.
- Danaher drops plans to buy Catalent, according to Bloomberg.
- About 300 people lined up Tuesday in front of Apple's first store in India, in Mumbai, inaugurated in the presence of the group's CEO, Tim Cook.
- The Glazer family may give up on selling Manchester United.
- GSK is buying Canadian company Bellus Health for $2 billion.
- Chinese regulators are expected to cut the more than $1 billion fine on Ant Group by a quarter and lower the charges against the Alibaba subsidiary, sources told Reuters.
- China Mobile is reportedly considering a takeover of Hong Kong telecommunications company HKBN, according to Reuters.
- Prometheus Biosciences is soaring after being bought by Merck at $200 a share.
- Capcom soars with the announcement of a new Monster Hunter.
- Cineworld abandons plans to sell its Eastern European and Israeli operations.
- Yum! Brands is pulling out of the Russian market.
- Ericsson 's CFO to leave in 2024.
- Eli Lilly raises planned investment in its Indiana manufacturing facilities to $3.7 billion.
- Volkswagen and Mercedes unveiled two new 100% electric premium models in China on Monday.
- Webuild and Lane win a $1bn contract in the US.
- Novartis suffers another setback in the US in its Gilenya litigation.
- Roche presents promising early data on divarasib in oncology.
- Top earnings today: Johnson & Johnson, Bank of America, Netflix, Lockheed Martin, Goldman Sachs, Prologis, Intuitive Surgical, Vale, Sika, Ericsson... All the agenda is here.